Ticker brief
PRME
last close
·
1 day
·
14 days
·
mkt cap
·
signals 14d
27
authors 14d
14
crowd 14d
+0.4σ
No price history on file for this name (likely non-equity or unlisted) — the “since then” column below stays blank.
Sentiment — last 14 days
daily mean sentiment, 2026-10-05 → 2026-10-15 · now +0.14 (−1 bearish … +1 bullish)
Who spoke14
| author | grade | trader score | signals | mean sent |
|---|---|---|---|---|
| @Brad_E_Schulz | C | · | 4 | +0.39 |
| @hiddensmallcaps | B | -0.87 | 4 | +0.41 |
| @OptionsFlowBoss | C | · | 3 | +0.38 |
| @OzmosiHealth | C | · | 2 | +0.10 |
| @UTEX_io | C | +0.04 | 2 | +0.35 |
| @harry03994688 | A | -0.16 | 2 | +0.60 |
| @GoldmanBanker | C | -1.56 | 2 | +0.60 |
| @cnfinancewatch | B | -1.23 | 2 | +0.20 |
| @BioStocks | C | -1.77 | 1 | +0.15 |
| @LogicalThesis | A | -1.21 | 1 | +0.80 |
| @MikeJTrades | C | · | 1 | +0.30 |
| @be4_the_h3rd | C | -3.02 | 1 | +0.70 |
| @TalkMarkets | C | · | 1 | +0.00 |
| @KakashiCapital_ | B | -0.19 | 1 | +0.00 |
Recent signals27of 27 in 14d — receipts included
| date (PT) | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|
| 2026-10-15 | @KakashiCapital_ | +0.00 | Bare ticker list suggests a watchlist but provides no stance or levels. | · | tweet ↗ |
| 2026-10-15 | @cnfinancewatch | +0.00 | Ticker accompanied only by unseen media, so stance requires chart context. | · | tweet ↗ |
| 2026-10-15 | @OptionsFlowBoss | +0.35 | Reports unusual bullish options-volume multiples during the first two trading hours. | · | tweet ↗ |
| 2026-10-15 | @hiddensmallcaps | +0.20 | Observes PRME rising as CRWV undergoes severe stress. | · | tweet ↗ |
| 2026-10-13 | @hiddensmallcaps | +0.70 | Added PRME at $3.42. — Explicit position addition at a stated execution price. | · | tweet ↗ |
| 2026-10-12 | @TalkMarkets | +0.00 | Article examines PRME volume anomalies and corporate mechanics. | · | tweet ↗ |
| 2026-10-12 | @cnfinancewatch | +0.40 | Maps four listed gene-editing companies to distinct technology platforms and leadership claims. | · | tweet ↗ |
| 2026-10-12 | @hiddensmallcaps | +0.55 | Added a small amount of PRME. — Author explicitly reports adding a little PRME and jokes about a future business-development deal. | · | tweet ↗ |
| 2026-10-09 | @harry03994688 | +0.50 | Presents AI-enabled biotech as a structural turnaround and highlights high-short-interest names benefiting from squeezes. | · | tweet ↗ |
| 2026-10-09 | @hiddensmallcaps | +0.20 | References a potentially constructive chart base without trade intent. | · | tweet ↗ |
| 2026-10-09 | @GoldmanBanker | +0.45 | Celebrates a 14% gain in under 24 hours after the move. | · | tweet ↗ |
| 2026-10-09 | @be4_the_h3rd | +0.70 | Celebrates PRME quickly reaching above $4 as another successful past call. | · | tweet ↗ |
| 2026-10-09 | @Brad_E_Schulz | +0.30 | Reports intraday sector breadth and qualifying biotech movers. | · | tweet ↗ |
| 2026-10-08 | @GoldmanBanker | +0.75 | Buying PRME shares at $3.56 for a longer-term swing. — Explicitly reports a new share entry with price and longer-term horizon. | · | tweet ↗ |
| 2026-10-07 | @Brad_E_Schulz | +0.50 | Lists stocks up at least 4% on at least 1.5 times average volume; capped at six. | · | tweet ↗ |
| 2026-10-07 | @MikeJTrades | +0.30 | Lists completed intraday gainers and trading descriptions; ticker cap limits extraction to six. | · | tweet ↗ |
| 2026-10-07 | @UTEX_io | +0.45 | Prime Medicine dosed the first patient in a global Phase 1/2 gene-therapy trial. | · | tweet ↗ |
| 2026-10-07 | @OptionsFlowBoss | +0.40 | Lists unusually bullish options-volume multiples during the first two trading hours. | · | tweet ↗ |
| 2026-10-07 | @Brad_E_Schulz | +0.30 | Quantifies intraday sector breadth and performance; ticker output is capped at six movers. | · | tweet ↗ |
| 2026-10-07 | @Brad_E_Schulz | +0.45 | Lists stocks up at least 4% on elevated intraday volume; capped at six. | · | tweet ↗ |
| 2026-10-06 | @OzmosiHealth | +0.00 | Prime Medicine schedules Phase 1 PM-577 results for year-end 2027. | · | tweet ↗ |
| 2026-10-06 | @OptionsFlowBoss | +0.40 | Lists unusually bullish options-volume multiples in early trading; capped at six tickers. | · | tweet ↗ |
| 2026-10-06 | @harry03994688 | +0.70 | Forecasts a biotech short squeeze driven by AI, improving success rates and falling long-term yields. | · | tweet ↗ |
| 2026-10-06 | @LogicalThesis | +0.80 | Reports a completed overnight PRME trade that generated a $9,300 gain. | · | tweet ↗ |
| 2026-10-06 | @UTEX_io | +0.25 | Reports first-patient dosing in a global Phase 1/2 gene-therapy trial. | · | tweet ↗ |
| 2026-10-05 | @OzmosiHealth | +0.20 | Prime Medicine announced the first patient dosed in a global Phase 1/2 PM577a trial. | · | tweet ↗ |
| 2026-10-05 | @BioStocks | +0.15 | PRME dosed the first patient in a global Phase 1/2 trial of PM577a. | · | tweet ↗ |
“Since then” = price move from the close on the signal's date (PT) to the latest close — what happened after they said it, not a backtest. A — means no trading session has closed since the signal yet. Sentiment is our extracted per-tweet score, −1…+1.